|Mr. Andrew J. Hykes||CEO, President & Director||863.78k||800.42k||1974|
|Mr. Mitchell C. Hill||Chief Financial Officer||811.08k||5.86M||1959|
|Dr. Thomas M. Tu M.D.||Chief Medical Officer||812.94k||2.85M||1973|
|Mr. Paul A. Koehn||Senior Vice President of Operations||N/A||N/A||1963|
|Mr. Kevin Strange||Senior Vice President of Finance, Accounting, Strategy & Business Development||N/A||N/A||N/A|
|Mr. John Hsu C.F.A.||Vice President of Investor Relations||N/A||N/A||N/A|
|Ms. Angela Ahmad||General Counsel & Secretary||N/A||N/A||N/A|
|Mr. Eric Khairy||Senior Vice President of Marketing||N/A||N/A||N/A|
|Mr. John R. Borrell||Senior Vice President of Sales||N/A||N/A||1967|
|Ms. Tara Dunn||Senior Vice President of Clinical Affairs & Market Development||N/A||N/A||N/A|
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Inari Medical, Inc.’s ISS governance QualityScore as of 28 November 2023 is 6. The pillar scores are Audit: 2; Board: 6; Shareholder rights: 8; Compensation: 6.